coteauBeta Get App
ASST

ASST

Strive, Inc.
$30.77
+13.71% Oct 21 close
Financial Services Compare
1M3M6M1Y2Y
-59%-21%+16%+53%+90%Oct 2025Oct 2026Apr 2026
ASSTSPY
1W
+24.7%
1M
+1.5%
3M
+142.9%
6M
+84.7%
YTD
+108.5%
1Y
+85.4%

Live chart

Loading live chart…

What they do

Strive, Inc. is an investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm, an investment adviser to an investment company which provides portfolio management for investment companies.

Financial Services · Asset Management

For information only · Important disclosures

Grades vs sector

No sector grades for ASST yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 Coteau Long Book
Not in the current book

News

More news
Before the Next Payout: The High-Yield Dividend Bundle to Buy Before November
24/7 Wall St. · 12h ago
Strive Raises $630M in SATS IPO, Keeps Bitcoin Allocation Open
CryptoProwl · Oct 20
Strive Closes Upsized IPO of SATS Preferred Stock
MT Newswires · Oct 20
Strive Buys $335 Million in Bitcoin After Investors Pour In $369 Million
decrypt · Oct 19
Michael Saylor Is Bullish on Bitcoin. Yet His Company's Money Is Going Somewhere Else.
Barchart · Oct 19

Key stats

Market value$3.1B
P/E (next 12 months, estimated)-32.1
52-week range$7.02 – $36.20
Revenue growth (latest quarter vs a year ago)+94.6%
Dividend yieldNo dividend
Analyst consensusStrong Buy (5)
Average analyst price target$38.80 (+26%)
Valuation and fundamentals

Valuation & fundamentals

Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
▼Piotroski F-score3/9
▲Analyst target+26% (5 analysts)

Discounted cash flow

Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (FY to 2024-12-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 13.24 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $-0.96 vs trailing $-204.80. Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin
–
Operating margin
-620.7%
FCF margin
-592.3%
Net margin
-591.2%
Return on equity
-3.3%
Return on invested capital
-3.6%
Net debt / EBITDA
–
Current ratio
7.6×
Interest cover
–
Cash conversion (OCF/NI)
–
Piotroski F-score 3/9 · last two fiscal years
✗ Positive net income✗ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved

Analysts

Mean target
$39
+26%
Analysts
5
Strong Buy
Range
$32–$56
low – high
● price · ◆ mean target

Annual history

FYRevenueNet incomeFree cash flow
2024$633.5K$-21.6M$-21.6M
2023$277.0K$-4.9M$-3.8M
2022$343.1K$-645.3K$-602.8K
2021$829.6K$14.9K$23.4K

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -8.6%.

Earnings

Next report: 2026-11-10 · before open · EPS est -0.21
26-0526-08-5.190.00
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-10-0.24-3.65-1389.8%
2026-05-14-2.40-5.19-116.3%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$2.9M+106.7%
2026-03-31$2.8M–
2025-12-31$1.5M–
2025-06-30$1.5M–
2025-03-31$1.4M–
Analyst actions
Maxim Group
2026-10-12 · main
Buy → Buy
PT $37
B. Riley Securities
2026-09-22 · main
Buy → Buy
PT $33
B. Riley Securities
2026-09-03 · main
Buy → Buy
PT $26
HC Wainwright & Co.
2026-08-11 · main
Buy → Buy
PT $36
TD Cowen
2026-07-22 · main
Buy → Buy
PT $28
Benchmark
2026-06-02 · init
 → Buy
PT $32
Insider trades
Sarkhani Arshia
Director, Chief Marketing Officer · 2026-10-05
SELL
$176.5K
Beirne Brian Logan
Director, Chief Legal Officer · 2026-10-05
SELL
$629.1K
Lavish James
Director · 2026-10-05
SELL
$184.5K
Macey Jonathan R
Director · 2026-10-05
SELL
$203.1K
Cole Matthew Ryan
Director, Chief Executive Officer · 2026-10-05
SELL
$1.8M
Pham Benjamin
Director, Chief Financial Officer · 2026-10-05
SELL
$131.9K
Rochard Pierre
Director · 2026-08-14
BUY
$199.4K
None
None · None
SELL
–
None
None · None
SELL
–
None
None · None
SELL
–
None
None · None
SELL
–
None
None · None
SELL
–

Stats refreshed 2026-10-21 13:41:02 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

How it worksDisclaimerTermsPrivacyData statusSend feedback
Beta 0.9 · Oct 21, 2026